A nurse is preparing to administer intravenous mannitol, an osmotic diuretic, to a client with increased intracranial pressure. Which of the following should the nurse identify as the purpose of the medication?
A.
Provide fluid hydration.
B.
Reduce edema of the brain.
C.
Increase cell size in the brain.
D.
Expand extracellular fluid volume.
The Correct Answer and Explanation is :
The correct answer is B. Reduce edema of the brain.
Explanation:
Mannitol is an osmotic diuretic commonly used in medical settings to manage increased intracranial pressure (ICP), a condition where there is an abnormal increase in pressure within the skull. The primary mechanism of action for mannitol involves its osmotic properties, which can effectively reduce brain edema.
When mannitol is administered intravenously, it acts as an osmotic agent in the bloodstream. Its high osmolarity draws water out of the brain’s extracellular space into the vascular system. This shift of fluid from the brain to the bloodstream helps decrease the volume of edema in the brain, which in turn reduces intracranial pressure. By alleviating the pressure on the brain tissue, mannitol helps prevent or mitigate damage caused by elevated ICP, which can be critical in managing conditions such as traumatic brain injury, brain tumors, or other pathologies leading to increased brain swelling.
Let’s review why the other options are incorrect:
A. Provide fluid hydration: Mannitol is not primarily used for fluid hydration. Its purpose is not to rehydrate the body but to manage elevated intracranial pressure by affecting fluid distribution in the body. While it does affect fluid balance, its main role is to reduce brain edema rather than provide hydration.
C. Increase cell size in the brain: Increasing cell size in the brain is counterproductive in the context of increased intracranial pressure. The goal of using mannitol is to reduce brain cell swelling and edema, not to increase cell size.
D. Expand extracellular fluid volume: Mannitol does not expand extracellular fluid volume in a beneficial way. Instead, it reduces the extracellular fluid volume in the brain by drawing fluid out of the brain tissue and into the bloodstream, which helps lower intracranial pressure.
Thus, the primary purpose of administering mannitol in this scenario is to reduce edema of the brain, effectively addressing the underlying issue of increased intracranial pressure.